germline
Showing 1 - 25 of 883
Germline BRCA-mutated HER2-negative Breast Cancer Trial in Beijing (Camrelizumab+Fluzoparib)
Enrolling by invitation
- Germline BRCA-mutated HER2-negative Breast Cancer
-
Beijing, Beijing, ChinaBreast Cancer, Peking University People's Hospital
Nov 14, 2022
Universal Germline Testing in the Community
Recruiting
- Cancer
- +2 more
- Invitae's 84 gene multi-cancer panel.
-
Rock Hill, South CarolinaCarolina Blood and Cancer Care Associates, PA'
Dec 5, 2022
PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES
Not yet recruiting
- BRCA Mutation
- +2 more
- Germinal BRCA
- (no location specified)
Mar 3, 2023
Germline and Somatic Pathogenic Variants in de Novo Metastatic
Active, not recruiting
- Metastatic Breast Cancer
- NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
-
Athens, GreeceEvangelia Moirogiorgou
Mar 7, 2023
Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the
Not yet recruiting
- Inherited Bone Marrow Failure Syndrome
- Familial Platelet Disorder With Predisposition to Myeloid Malignancies
- imatinib
- TruSight Oncology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2023
PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Stanford, Boston, Cleveland (Sirolimus,
Not yet recruiting
- PTEN Gene Mutation
- +2 more
- Sirolimus
- Placebo
-
Stanford, California
- +2 more
Oct 5, 2023
TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)
Recruiting
- TNBC - Triple-Negative Breast Cancer
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 27, 2023
Mesothelioma Patients and Their Family Members With Germline
Recruiting
- Mesothelioma
- Families
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Lung Cancer Trial in Boston, Nashville
Active, not recruiting
- Lung Cancer
-
Boston, Massachusetts
- +1 more
Dec 28, 2022
Prostate Cancer Trial (Educational intervention.)
Not yet recruiting
- Prostate Cancer
- Educational intervention.
- (no location specified)
Jul 19, 2022
Germline Variant Carriers With BRCA1 or BRCA2
Recruiting
- BRCA1 and/or BRCA2 Variant Carriers
- +3 more
-
Okayama, JapanOkayama University
Dec 25, 2022
Integrative Sequencing In Germline and Hereditary Tumours
Active, not recruiting
- Hereditary Cancer Syndrome
- +3 more
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 21, 2022
Causative Variants in Germline DNA Samples From Hypertension
Recruiting
- Breast Carcinoma
- Laboratory Biomarker Analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
Oct 15, 2022
Causative Variants in Germline DNA Samples From Peripheral
Recruiting
- Breast Carcinoma
- Neuropathy
- Laboratory Biomarker Analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
Oct 15, 2022
Causative Variants in Germline DNA Samples From Congestive Heart
Recruiting
- Breast Carcinoma
- Laboratory Biomarker Analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
Oct 15, 2022
Searching for Novel Germline Mutations in Lobular Breast Cancer
Recruiting
- Lobular Breast Carcinoma
- +3 more
- Illumina panel
-
Milan, ItalyEuropean Institute of Oncology
Sep 12, 2022
Universal Genetic Testing Versus Guidelines-Directed Testing for
Recruiting
- Breast Cancer
-
Amman, JordanKing Hussein Cancer Center
Aug 17, 2022
GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)
Not yet recruiting
- GATA2 Gene Mutation
- Biological samples (blood and bone marrow samples).
-
Angers, France
- +16 more
Jul 31, 2023
Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers Trial (Niraparib)
Not yet recruiting
- Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
- (no location specified)
Feb 21, 2022
Breast & Ovarian Cancer Risk Detection
Recruiting
- Adnexal Mass
- +3 more
- OVA360
-
Austin, TexasSilvana Franco
Jul 20, 2022
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or
Recruiting
- Ovarian Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jul 13, 2022
Universal- Versus Guidelines-Directed Genetic Testing for
Recruiting
- Genetic Predisposition
-
Amman, JordanKing Hussein Cancer Center
Aug 17, 2022
Molecular Profiling in Prostate Cancer
Recruiting
- Prostate Cancer Metastatic
- +4 more
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Mar 15, 2022
Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)
Not yet recruiting
- Triple Negative Breast Neoplasms
- +7 more
- Pembrolizumab
- +4 more
- (no location specified)
Aug 1, 2022
Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8
Recruiting
- Prostate Adenocarcinoma
- +5 more
- Discussion
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 1, 2022